Khiron Life Sciences Stock Today
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Khiron Life has about a 26 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada. Khiron Life is traded on OTC Exchange in the United States. The company has 216.39 M outstanding shares. More on Khiron Life Sciences
Moving together with Khiron Pink Sheet
Moving against Khiron Pink Sheet
Khiron Life Sciences cannot be verified against its exchange. Apparently, Khiron Life is not available for investing at the moment. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
RefreshKhiron Pink Sheet Highlights
| Thematic Idea | Iron (View all Themes) |
| Business Concentration | Iron, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Khiron Life Sciences [KHRNF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Micro-Cap' category with a current market capitalization of 17.83 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Khiron Life's market, we take the total number of its shares issued and multiply it by Khiron Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Khiron Life Sciences classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 216.39 M outstanding shares.
Khiron Life Sciences has accumulated about 5.82 M in cash with (20.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03.
Check Khiron Life Probability Of Bankruptcy
Khiron Stock Against Markets
Try Other Suggestions
Be your own money manager
Our tools can tell you how much better you can do entering a position in Khiron Life without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Khiron Life Corporate Management
| Juan Alvarez | VP Regulations | Profile | |
| Alvaro Torres | CEO CoFounder | Profile | |
| ACA ACWA | Co Sec | Profile | |
| Helen ACA | Interim Officer | Profile | |
| Franziska Katterbach | Pres Europe | Profile | |
| Manuel Buendia | VP Operations | Profile | |
| Luis Chavez | Country Mexico | Profile |
Other Information on Investing in Khiron Pink Sheet
Khiron Life financial ratios help investors to determine whether Khiron Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Khiron with respect to the benefits of owning Khiron Life security.